CMS decision not to cover Alzheimer’s treatment a bad one
CMS decision not to cover Alzheimer’s treatment a bad one NCBIO stands in solidarity with patient advocates and industry leaders in opposing the Centers for Medicare and Medicaid Services’ draft...
View ArticleClik here to view.
Biotech joins efforts to aid in humanitarian relief in Ukraine
Biotech joins efforts to aid in humanitarian relief in Ukraine The biotech and life sciences industry is coming together to donate a range of critical medical supplies, equipment, and medications to...
View ArticleBIO: CMS decision enormous setback for Alzheimer’s patients, dangerous...
BIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit...
View ArticlePart D drug price “negotiation” comes at cost of jobs, investment, cures
Part D drug price “negotiation” comes at cost of jobs, investment, cures Update: The House passed the Inflation Reduction Act on Friday, Aug. 12. This past weekend, the U.S. Senate passed the...
View ArticleExpanding COVID IP waiver would harm small, medium enterprises, CSBA says
Expanding COVID IP waiver would harm small, medium enterprises, CSBA says Every member of the Council of State Bioscience Associations signed a letter to President Joe Biden expressing serious...
View ArticleWhere things stand with the TRIPS waiver
Where things stand with the TRIPS waiver It’s been a while since we’ve talked about what’s going on at the WTO. Here’s the latest news — and why extending the waiver of COVID-19 vaccine IP is still a...
View ArticleClik here to view.
Collaboration and statewide support make North Carolina a thriving hub of...
Collaboration and statewide support make North Carolina a thriving hub of urgently needed innovation in rare disease. The rarest day on the calendar is the one that does not even occur in every year:...
View ArticleClik here to view.
Study projects extensive damage to drug development, jobs from drug-pricing...
Study projects extensive damage to drug development, jobs from drug-pricing policies A new study estimates that there would be 237 fewer FDA approvals of new medicines over the next decade and 1.1...
View ArticleAMR is a silent killer that threatens our health in North Carolina and beyond
AMR is a silent killer that threatens our health in North Carolina and beyond The small red bump on my son's hand looked at first like a bug bite. But when the hand swelled to the point of...
View ArticleStartups struggle with new R&D tax rule
Startups struggle with new R&D tax rule A 2022 tax rule requiring the amortization of research and development expenses has created significant challenges for many life sciences startups and...
View ArticleNC treasurer: NC hospitals use 340B to profit a patient’s expense
NC treasurer: NC hospitals use 340B to profit a patient’s expense A new report from the North Carolina State Treasurer found North Carolina hospitals use the federal 340B program to profit at the...
View ArticleIn Congress, an EPIC move to support North Carolina life sciences
In Congress, an EPIC move to support North Carolina life sciences North Carolina is a leading hub of medical innovation. Our state is home to elite research universities, state-of-the-art...
View Article